Show simple item record

AuthorZolezzi, Monica
Available date2016-08-29T06:26:50Z
Publication Date2016-04-19
Publication NameNeuropsychiatric Disease and Treatment
Identifierhttps://dx.doi.org/10.2147/NDT.S100908
CitationZolezzi, Monica, "Medication management during electroconvulsant therapy" Neuropsychiatric Disease and Treatment 2016:12, 931-939
ISSN1178-2021
URIhttps://dx.doi.org/10.2147/NDT.S100908
URIhttp://hdl.handle.net/10576/4702
AbstractElectroconvulsive therapy (ECT) has demonstrated to be highly effective and safe, even life saving for many psychiatric disorders such as major depression, bipolar disorder and schizophrenia. Most patients who require ECT are also on concurrent pharmacotherapy. As such, the objective of this article is to provide a review of the most recent literature focusing on the medications used during an ECT procedure and on the effects of concurrent psychiatric and non-psychiatric medications on the effectiveness and safety of ECT. The review also attempts to summarize the recommendations derived from existing documents to guide pharmacotherapy decisions for patients undergoing ECT. For this purpose, using electronic databases, an extensive search of the current literature was made using ECT and medications or drug classes as keywords.
SponsorQatar University - Start Up Grant
Languageen
PublisherDove Press
SubjectECT
medications
drug interactions
TitleMedication management during electroconvulsant therapy
TypeArticle
Pagination931-939
Volume Number12
dc.accessType Open Access


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record